Global Urothelial Cancer Market Analysis


  • Type: Oncology area
  • Published : March 2021
  • Region: Worldwide
  • Country: Other
  • Report ID : 248

  • Format: PPT, PDF

Global Urothelial Cancer Market – Growth, Trends, and Forecasts (2019 – 2028)


Report Overview

The global Urothelial Cancer drugs market size stood at USD 955 million in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period

Surging volume of patients suffering from urothelial cancer and high recurrence rate of patients, increasing prevalence of geriatric population across the globe, rising emergence and priority of targeted therapy among biopharmaceutical companies, rising awareness among people for early diagnosis and treatment, increasing adoption of unhealthy lifestyle of the people are some of the major as well as vital factors which will likely to augment the growth of the urothelial cancer drugs market in the projected timeframe of 2019-2028. On the other hand, rising development of new novel drugs by various pharmaceutical companies along with surging levels of investment in research activities which will further contribute by generating massive opportunities that will lead to the growth of the urothelial cancer drugs market in the above mentioned projected timeframe.

Market Drivers

Increased knowledge about specific cancer biomarkers is fuelling revenue opportunities for diagnostic companies that aid in the treatment of various cancer patients through improvement in detection (both, accuracy and time spent). Technological advancements in the field of biotechnology have enhanced the identification of potential cancer biomarkers, and some of the recent diagnostics adopted for detection and disease progression of urothelial carcinoma include the Immuno-Histochemical assay test, In Situ hybridization test, biopsy, and cystoscopy.


1. Global Urothelial Cancer Market Overview………………………………………..,
A. Market Size
2. Market Growth Drivers………………………………………………………………….
A. Rise in Global Prevalence of Urothelial Cancer
B. Growing R&D Investments and Reimbursement Policies
3. Major Urothelial Cancer……………………………………………………………………………
A. Urothelial carcinoma
B. Squamous Cell Carcinoma
C. Adenocarcinoma
4. Urothelial Cancer Market Segmentation………………………………………………
A. Class
I. Immunotherapy
II. Chemotherapy
III. Preservation Therapy
B. Distribution Channel
I. Hospital
II. Specialty Clinics
III. Others
C. Geography
I. North America Market Analysis
II. Europe Market Analysis
III. Asia-Pacific Market Analysis
IV. Middle-East and Africa Market Analysis
5. Major Drugs Market Share of Urothelial Cancer………………………………
A. Market Analysis, Insights and Forecast – By Revenue
6. Competitive Landscape…………………………………………………………………
A. Major Players
B. Products in Pipeline
7. Key Company Profiles…………………………………………………………………..
A. Pfizer Overview, Product & Services, Strategies & Financials
B. Roche Overview, Product & Services, Strategies & Financials
C. GlaxoSmithKline plc., Product & Services, Strategies & Financials
8. Healthcare Policies and Regulatory Landscape……………………………………
A. Policy changes and Reimbursement scenario
9. Factors Driving Future Growth…………………………………………………………
A. New Trends and Development of Urothelial Cancer Market
B. Future Opportunities
10. Conclusion

Market Segmentation

By Class:

The therapeutic landscape is expected to witness a paradigm shift toward combination therapies and novel immuno-oncology products. Combination regimens, particularly checkpoint inhibitors, are likely to be introduced in the first line setting. Immune checkpoint blockade therapy is expected to replace the current standard of care in bladder cancer in the foreseeable future. Therapeutic development in second line setting for chemotherapy-intolerant patients is expected to have a major impact in the urothelial cancer space. Urothelial cancer presents a strong opportunity for introducing first-in-class treatments due to high unmet needs. Opportunities remain in the non-muscle invasive bladder cancer (NMIBC) setting where there exists an unmet need for treatment options for patients who are BCG-intolerant or ineligible.

By Disease Indication:

Urothelial cell bladder cancer accounts for 90% of bladder cancer cases worldwide and is especially common in developed nations. This subtype is highly associated with chemical exposure, such as occupational exposure or tobacco smoke, due to urothelial direct exposure.

By Distribution Channel:

Based on distribution channel, the Urothelial Cancer drugs market has been segmented into hospital pharmacies, clinics, and others. The retail pharmacies segment dominated the Urothelial Cancer drugs market, in terms of revenue. Preference for distribution through retail pharmacies, high number of prescriptions filed at retail pharmacies, and rise in the number of retail pharmacies across the globe are some of the major factors fuelling the growth of the retail pharmacies segment.

By Region:

Americas dominated the global bladder cancer market owing to the increase in the occurrence of bladder cancer, innovative healthcare solutions, advanced health care infrastructure, and increasing concern about bladder problems. Europe accounts for the second largest share of the market due to the availability of better healthcare solutions and rise in bladder cancer cases in the region. The Asia Pacific bladder cancer market is predicted to expand at a high growth rate due to the growing awareness about bladder diseases and innovative diagnostic and treatment options. Major players are investing in the developing countries in Asia as it is a lucrative market for bladder cancer, thus leading to market growth.

Top 5 Major Players

The global Urothelial Cancer Market is highly competitive, and the prominent players in the market have adopted various strategies to garner maximum market share. These include collaboration, product launch, partnership, and acquisition. Major players operating in the market include GlaxoSmithKline, Genentech, Novartis, Pfizer and Roche.

Research Methodology

Insights10 will provide you reports within 10 key parameters which are:

  1. Market overview
  2. Market growth drivers & restraints
  3. Epidemiology or disease type
  4. Market segmentation
  5. Market share
  6. Competitive landscape
  7. Key company profiles
  8. Healthcare policies & regulatory framework
  9. Reimbursement scenario
  10. Factors driving future growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision making for business stakeholders. Our focused approach to develop reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

Our analysis methodology involves three critical stages:

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers and researchers across countries through which we engage with local experts to gather key data points and assumptions around each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain the high level of accuracy and consistency. The market data is analysed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, market share as well as segment-level analysis of the specific market. Our report includes precise, to the point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

  • Statistical Databases
  • Company Websites/Annual Reports
  • Trade Publications
  • Online Databases
  • Published Research Reports
  • Whitepapers
  • Press Releases of Key Market Players

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameter and micro indicators. The macro parameters includes changes in government policies, demand and supply of the market, government intervention programs and major market share. The micro indicators GDP growth, market size, market volume etc. We also understand nuances specific to each country like US, Canada, India, Germany, etc. and have worked across 60+ countries and hence no only understand global trends, but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. start with large overall market and segment different areas and bottom-up approach i.e. start with population and epidemiology and roll up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach mainly used for new product forecasting and bottom-up approach is used for demand estimation of any product for different countries summed up to form total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and Africa for the period of 2020 to 2028. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape and policy and regulatory scenario and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases and the company level averages etc.

We make sure to finalize the numbers in alignment to the market research. Firstly, our internal experts ensure thorough validation and checking to ensure the accurate and precise analysis and then validation is also done using multiple data analysis model.  Two level validation is done and entails finalization of report scope and to way of representation pattern.

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analysed and synthesized. A second series of interviews are done if necessary to check and validate. The future opportunities are analysed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results are then, interpreted by considering following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue / volume
  • Analyzing current needs and determining penetration to estimate market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and its impact to the different segments within the market.
Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumptions.
The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy this report, please complete the form below.

    We value your inquiry and offer free customization with every report to fulfil your exact research needs.

    This website is secure and your personal details are safe.

    This report addresses

    • Market intelligence to enable effective decision making
    • Growth opportunities and trend analysis
    • Competitive benchmarking
    • Historical data & forecasts
    • Regional opportunities

    Need more?

    • Speak to our analyst to know how this research was put together
    • Add more countries or regions as part of customisation
    • Understand how this report can have direct impact on your revenue

    Get a custom report based on your requirements